Psychiatrists, neurobiologists and neuropharmacologists are offered a comprehensive view on basic and clinical aspects of older antiepileptic drugs and the most promising candidates of the new antiepileptic drugs, gabapentin and lamotrigine. International experts attempted with their presentations at the recent international symposium to give a state-of-the-art report on basic mechanisms of action as well as clinical data on efficacy and tolerability of old and new antiepileptic drugs in psychiatry. The data bring together the experience of the last two decades of clinical use of mood stabilisers, especially antiepileptic drugs. Insights into the benefits of the new drugs (especially gabapentin and lamotrigine) resulted in the first trials of differential, symptom and course of disease oriented treatment of patients with bipolar disorders (manic depressive illness), including a new realisation of the strengths and limitations of each mood stabilizer.
Publisher: S Karger AG
Number of pages: 94
Weight: 310 g
You may also be interested in...
Thank you for your reservation
Your order is now being processed and we have sent a confirmation email to you at
When will my order be ready to collect?
Call us on or send us an email at
Unfortunately there has been a problem with your order
Please try again or alternatively you can contact your chosen shop on or send us an email at